IFITM proteins restrict antibody-dependent enhancement of dengue virus infection - PubMed (original) (raw)

IFITM proteins restrict antibody-dependent enhancement of dengue virus infection

Ying Kai Chan et al. PLoS One. 2012.

Abstract

Interferon-inducible transmembrane (IFITM) proteins restrict the entry processes of several pathogenic viruses, including the flaviviruses West Nile virus and dengue virus (DENV). DENV infects cells directly or via antibody-dependent enhancement (ADE) in Fc-receptor-bearing cells, a process thought to contribute to severe disease in a secondary infection. Here we investigated whether ADE-mediated DENV infection bypasses IFITM-mediated restriction or whether IFITM proteins can be protective in a secondary infection. We observed that IFITM proteins restricted ADE-mediated and direct infection with comparable efficiencies in a myelogenous leukemia cell line. Our data suggest that IFITM proteins can contribute to control of secondary DENV infections.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1

Figure 1. IFITM proteins restrict both direct and ADE-mediated DENV infection of K562 cells.

(A) K562 cells were treated with the indicated concentrations of human interferon-α or mock treated, and lysed for Western blot analysis 48 h later, using an antibody that recognizes IFITM1 alone, or one that recognizes both IFITM2 and IFITM3. (B) K562 cells were stably transduced to express human IFITM1, 2, or 3 or with the control vector pQCXIP. IFITM protein expression was measured by Western blot using an anti-c-myc antibody. (C) Stably transduced K562 cells characterized in panel B were infected with an MLV-based retrovirus expressing EGFP and pseudotyped with MACV or IAV H5 entry proteins, as previously described . Infection was determined by flow cytometry, and normalized to K562 cells transduced with vector alone. (D) K562 cells characterized in panel B were infected with infectious DENV2 NGC strain (labeled “DENV2” for virus only) at the indicated MOI, or the same amount of infectious DENV2 pre-opsonized with enhancing titers of antibodies against DENV structural proteins prM or E (“+2H2” and “+4G2” respectively) , . Cells were washed after 1.5 h and incubated for ∼24 h. Intracellular staining of DENV antigen was performed with a DyLight-649-conjugated antibody against prM and infection was determined by flow cytometry. Experiment is representative of three with similar results. (E) An experiment similar to that shown in panel D was performed except that infection was assayed by measuring viral loads in the supernatant by plaque assays using BHK cells. (F) An experiment similar to that in panel D was performed, except that J774A.1 murine macrophage cells were stably transduced to express murine orthologs of IFITM1, 2, or 3 or with the control vector pQCXIP. Stably transduced cells were infected with infectious DENV2 NGC strain at ∼MOI 5 and incubated for ∼2 days before harvesting for flow cytometry. Error bars indicate standard error. Single and double asterisks indicate statistically significant (P<0.05 and P<0.005, respectively) differences between IFITM protein expressing and control cells for corresponding infection conditions.

Figure 2

Figure 2. Endogenous IFITM1 restricts both direct and ADE-mediated DENV infection of K562 cells.

(A) K562 cells were stably transduced to express shRNA targeting IFITM1, 2, or 3 or non-targeting control shRNA (scrambled). IFITM protein expression was measured by Western blot, as in Fig. 1A. (B) shRNA-transduced K562 cells characterized in panel A were infected with the indicated pseudoviruses as described in Fig. 1C. (C) shRNA-transduced K562 cells characterized in panel A were infected with infectious DENV2 NGC strain as described in Fig. 1D. Error bars indicate standard error. Single and double asterisks indicate statistically significant (P<0.05 and P<0.005, respectively) differences between cells expressing IFITM1 and control shRNA for corresponding infection conditions. Experiment is representative of three with similar results.

Figure 3

Figure 3. IFITM proteins restrict direct and ADE-mediated infection with similar efficiencies.

(A) K562 cells stably transduced to express human IFITM1, 2, or 3 or with control vector were infected as in Fig. 1D, except that an MOI of 3.0 was used for non-opsonized DENV, and an MOI of 1.0 was used for DENV pre-opsonized with the antibodies 2H2 or 4G2. Different MOIs were used to achieve comparable infection levels between direct and ADE-mediated infection. (B) K562 cells stably transduced to express control shRNA or shRNA targeting IFITM1 were infected as described in Fig. 2C, except that an MOI of 1.6 was used for non-opsonized DENV, and an MOI of 1.0 was used for DENV pre-opsonized with the indicated antibodies. Standard error bars are shown. For each transduction condition, differences between direct infection and ADE-mediated infection were not statistically significant.

Similar articles

Cited by

References

    1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–496. - PMC - PubMed
    1. Halstead SB. Dengue. Lancet. 2007;370:1644–1652. - PubMed
    1. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189:1411–1418. - PubMed
    1. Halstead SB. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med. 1970;42:350–362. - PMC - PubMed
    1. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411–419. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources